Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma

Di Wang,1,* Wei Zhang,2,* Xudong Gao,2 Huifang Kong,2 Huixin Zhang,2 Jiagan Huang,2 Meng Zhang,1 Xiujuan Chang,2 Zhen Zeng1,2 1 302 Clinical Medical School, Peking University, Beijing, People’s Republic of China; 2Senior Department of Liver Disease Medicine, Chinese PLA General Hospi...

Cijeli opis

Bibliografski detalji

Glavni autori:	Wang D, Zhang W, Gao X, Kong H, Zhang H, Huang J, Zhang M, Chang X, Zeng Z
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2026-04-01
Serija:	Cancer Management and Research
Teme:	Unresectable Hepatocellular Carcinoma Transarterial Chemoembolization PD-1 Inhibitor Regorafenib Second-Line Therapy
Online pristup:	https://www.dovepress.com/transarterial-chemoembolization-combined-with-regorafenib-and-pd-1-inh-peer-reviewed-fulltext-article-CMAR
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!